BioSpace News Archive

Spartan Medical Inc., a Service-Disabled Veteran-Owned Small Business founded in 2008, is proud to partner with Altapure, LLC, a manufacturer of innovative products, to bring its AP-4 High-level Disinfection-System (HLDS) to the national market . This critically needed, advanced-ultrasonic-technology ensures that all healthcare an

RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) (“RegeneRx”), a clinical-stage drug development company focused on tissue protection, repair and regeneration announced today that enrollment in the 700-patient, phase 3 clinical trial for dry eye syndrome (ARISE-3) is expected to be completed in November, 2020, and that th

§ Received first payments from $47.5 million contract with Wisconsin client on October 9, 2020 § Wisconsin client upped avg. kit purchases from 2,100+/day to 3,500+/day on October 12, 2020 § Todos has completed equipment purchases for signed Q3/20 reagent supply agreements § Existing contracts have the potential to deliver over $60 million in revenue to Todos by end Q2/2021 NEW YORK, NY, REHOVAT, ISRAEL, SINGAPORE, Oct. 14, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todo

Summit Biolabs Announces Strategic Collaboration with Colorado Center for Personalized Medicine (CCPM) to Develop and Commercialize Saliva Liquid-biopsy Tests for COVID-19 and for Head & Neck Cancer [14-October-2020] AURORA, Colo. , Oct. 14, 2020 /PRNewswire/ -- Summit Biolabs, Inc., an early-stage molecular diagnostics company specializing in saliva-based testing

Sentrics Holdings, LLC., today announced that its revolutionary new platform, Engage360SM, which turns the resident TV into an interactive engagement engine, is now available

As the nation continues to struggle with the COVID-19 pandemic, leading national public health organizations warn that this year’s influenza (flu) season amid the pandemic may pose a looming double threat for the health of Americans. The American Lung Association, the American Diabetes Association (ADA) and the American Heart Association

Two studies published today in Blood Advances suggest people with blood type O may have a lower risk of COVID-19 infection and reduced likelihood of severe outcomes, including organ complications, if they do get sick.

PROSPECT ABSORB, a randomized substudy, showed treatment of high risk plaques with BVS is safe and associated with favorable long-term clinical outcomes compared to GDMT alone BEDFORD, Mass.--( BUSINESS WIRE )-- Infraredx, a Nipro Company, a pioneer in intravascular imaging for mapping coronary artery disease, announced positive results from the PROSPECT II and PROSPECT ABSORB studies, presented today as a late-breaking clinical trial at TCT Connect,

Pediatric Health Care Alliance has completed a merger with New Tampa Pediatrics and Dr. Jaydeep Patel. PHCA has continued plans for expansion in Tampa Bay through new clinical locations and mergers and acquisitions.

In lieu of an in-person update to the media, Dr. Theresa Tam, Canada’s Chief Public Health Officer, issued the following statement